Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Oncofertility
  • Reduced price
Neurobiology of Disease

Neurobiology of Disease

9780199937837
2,000.70 zł
1,800.63 zł Save 200.07 zł Tax included
Lowest price within 30 days before promotion: 1,800.63 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
The second edition of Neurobiology of Disease includes nearly 200 articles surveying all major disorders of the nervous system in both adults and children, focusing on relevant diagnosis and treatments from the perspective of cutting edge clinical and basic neurobiological research. Akin to an encyclopedia of every neurologic disorder, this comprehensive work is ideal for graduate and medical school students, residents, and candidates preparing for their board certification examinations. Each chapter is illustrated with detailed figures, supplemented with descriptive and diagnostic tables, and thoroughly referenced for further investigations. The books editors, Michael Johnston, Harold Adams, and Ali Fatemi bring their unique expertise in clinical and research neurology to the overall scope of this work. To further enhance the scope and quality of this new edition, the following Section Editors provided oversight of their respective sections::· Movement Disorders- Joel Perlmutter, Washington University· Dementias- David Knopman, Mayo Clinic· Motorneuron Diseases- Merit Cudkowicz, Massachusetts General Hospital· Paroxysmal Disorders- Solomon Moshe, Albert Einstein College of Medicine· Pediatric Neurology and Developmental Disorders- Tanjala Gipson and Deepa Menon, Kennedy Krieger Institute and Johns Hopkins University· Neuroimmunological Diseases- Carlos Pardo-Villamizar, Johns Hopkins University· Cerebrovascular Diseases- Harold Adams, University of Iowa· Peripheral and Autonomic Nervous System Disorders and Pain- Nicholas Maragakis, Johns Hopkins University· Neoplastic and Paraneoplastic Diseases- Lisa DeAngelis, Memorial Slaon-Kettering Cancer Center
Product Details
OUP USA
87554
9780199937837
9780199937837

Data sheet

Publication date
2016
Issue number
1
Cover
hard cover
Pages count
1434
Dimensions (mm)
216 x 279
Weight (g)
3198
  • SECTION I: Movement Disorders (Joel Perlmutter, Washington University); 1. History of Parkinsonism; Michael Silver, MD and Stewart A. Factor, DO; 2. Parkinson Disease: Pathophysiology, Clinical Manifestations and Course including Diagnosis and Differential Diagnosis; Michael J. Soileau, MD and Kelvin L. Chou, MD; 3. Parkinson Disease: Treatment, Current Clinical Trials; Thien Thien Lim, MD and Hubert H. Fernandez, MD; 4. Parkinson Syndromes: Multiple System Atrophy; Melvin W. Kong, MD and Ejaz A. Shamim MD, MS; 5. Parkinson Syndromes: Progressive Supranuclear Palsy; Vikas Kotagal, MD, MS and Praveen Dayalu, MD; 6. Parkinson Syndromes: Corticobasal Degeneration; Sami Barmada, MD, PhD; 7. Huntington Disease: Etiology, Genetics, and Clinical Manifestations; Roger L. Albin, MD and Henry L. Paulson, MD, PhD; 8. Huntington Disease: Treatment, Current Clinical Trials; Charles S. Venuto, PharmD and Karl Kieburtz, MD, MPH; 9. Essential Tremors; Arif Dalvi, MD, MBA, Kelly E. Lyons, PhD, and Rajesh Pahwa, MD; 10. Dystonia: History and Classification; H. A. Jinnah, MD, Cecilia N. Prudente, MD, Samuel J. Rose, MD and Ellen J. Hess, MD; 11. Dystonia: Pathophysiology, Clinical Manifestations and Course Including Diagnosis, and Differential Diagnosis, Treatment, Current Clinical Trials; Jeri Yvonne Williams, MD and David G. Standaert, MD, PhD; 12. Paroxysmal Dyskinesias; Olga Waln, MD and Joseph Jankovic, MD.; 13. The Expanded Polyglutamine Tract Spinocerebellar Ataxias; Elsdon Storey, MD; 14. Ataxias: Autosomal Recessive and other Ataxias; Vikram G. Shakkottai, MD, PhD; SECTION II: Dementias (David Knopman, Mayo Clinic); 15. Alzheimers Disease: Pathology and Pathogenesis; Bradley T Hyman, MD, Beatriz G Perez-Nievas, MD, Isabel Barroeta-Espar, MD, Alberto Serrano-Pozo, MD, Matthew Frosch, MD, and Teresa Gomez-Isla, MD; 16. Alzheimers Disease: Clinical Manifestations and Diagnostic/Differential Diagnosis; Michael S. Rafii, MD, PhD; 17. Alzheimers Disease: Management and Treatment; Gregory A. Jicha, MD, PhD and Frederick A. Schmitt, PhD; 18. Frontotemporal Degenerations; Jonathan Graff-Radford, MD, and Keith A. Josephs, MD, MST, MSc; 19. Diagnosis and Therapy for Lewy Body Dementia; Bela R. Turk, MD and Ali Fatemi, MD; 20. Pathogenesis of Lewy Body Dementia; Jagan A. Pillai, MD, PhD and James B. Leverenz, MD; 21. Cerebrovascular Dementia; Rahul Karamchandani, MD and Nancy R. Barbas, MD, MSW; SECTION III: Motorneuron Diseases (Merit Cudkowicz, Massachusetts General Hospital, Harvard University); 22. Types of MNDS; Nimish Thakore, MD and Erik P. Pioro, MD, PhD; 23. Clinical Presentations, Diagnostic Criteria, Lab Testing; Nimish Thakore, MD and Erik P. Pioro, MD, PhD; 24. Symptomatic Care; Matthew Gladman, MD and Lorne Zinman, MD, MSc; 25. ALS: Epidemiology; eilis J. OReilly, ScD; 26. ALS: Pathogenesis; Laura Ferraiuolo, MD and Stephen J. Kolb, MD; 27. ALS: Insights from Genetics; Matthew B. Harms, MD and Timothy M. Miller, MD, PhD; 28. ALS: In Vitro and In Vivo Disease Models; Brian J. Wainger, MD, PhD; 29. ALS Pathology; Brent T. Harris, MD, PhD, Galam A. Khan, MD, and Saed Sadeghi, MD; 30. ALS: Clinical Trials Past Reflections Informing New Directions; Katharine A. Nicholson, MD and James D. Berry, MD; 31. Upper Motor Neuron Disorders: Hereditary Spastic Paraplegia and Primary Lateral Sclerosis; John K. Fink, MD; 32. UMN Disorders (HSP and PLS): Pathogenesis, Insights from Genetics, In Vitro and In Vivo Disease Models, Pathology and Clinical Trials; Sabrina Paganoni, MD, PhD and Nazem Atassi, MD, MMSc; 33. SMA: Pathogenesis; Umrao R. Monani, PhD and Darryl C. De Vivo, MD; 34. SMA: Insights from Genetics; Arthur H.M. Burghes, MD and Vicki L. McGovern, MD; 35. SMA: In Vitro and In Vivo Models of Spinal Muscular Atrophy; W. David Arnold, MD and Arthur H.M. Burghes, MD; SECTION IV: Paroxysmal Disorders (Solomon Moshe, Albert Einstein College of Medicine); 36. Biological Basis of Primary Generalized Epilepsies-Genetics; Carla Marini, MD and Renzo Guerrini, MD; 37. Biological Basis of Primary Generalized Epilepsies - Pathophysiology; Mark W. Youngblood, MD and Hal Blumenfeld, MD; 38. Temporal Lobe Epilepsy; Edward H. Bertram, MD; 39. Focal Cortical Dysplasias; Ali Mahta, MD and Peter B. Crino, MD, PhD; 40. Biological Bases of Symptomatic Generalized Epilepsies in Children; Dragos A. Nita, MD, Miguel A. Cortez, MD, Jose Luis Perez Velazquez, MD, and O. Carter Snead 3rd, MD; 41. Epilepsies that Occur Predominantly in Girls; Lynette G Sadleir, MD, Jozef Gecz, MD, and Ingrid E Scheffer, MD; 42. Epidemiology of Epilepsy: Incidence, Prevalence, and Risk Factors; Dale C Hesdorffer, PhD, MPH; 43. Clinical Presentation, Diagnosis, and Course- Epilepsy Syndromes with Focal Seizures; Alex Boro, MD and Jerome Engel, Jr., MD; 44. Medical Management of Epilepsy; Jules C. Beal, MD and Emilio Perucca, MD; 45. Neuroimaging in Epilepsy; William A. Gomes, MD, PhD; 47. Alternative Therapies for Epilepsy: Dietary Treatments; Carl E. Stafstrom, MD, PhD; 48. Migraine and Other Headache Disorders; Robert W. Charlson, MD and Matthew S. Robbins, MD; 49. Neurobiology of Migraine; Victor Rosenfeld, MD and John Stern, MD; SECTION V: Pediatric Neurology and Developmental Disorders (Tanjala Gipson and Deepa Menon, Kennedy Krieger Institute and Johns Hopkins University); 50. Autism and Intellectual Disabilities: Overview of Autism and Intellectual Disabilities; Tanjala T. Gipson, MD and Michael V. Johnston, MD; 51. Tuberous Sclerosis Complex: Pediatric Aspects; Tanjala T. Gipson, MD, Andrea Poretti, MD, Rebecca McClellan, MGC, CGC, and Michael V. Johnston, MD; 52. Neurofibromatosis Type 1; David S. Wolf, MD, PhD; 53. Neurobiology of Autism and Intellectual Disability: Fragile X Syndrome; Dejan B. Budimirovic, MD and Megha Subramanian, BA; 54. Autism and Intellectual Disabilities: PTEN Gene mutation; Deepa U. Menon, MBBS, MD; 55. Rett Syndrome; C.L. Smith-Hicks, MD and SakkuBai Naidu, MD; 56. Angelman Syndrome; Kristin W. Bara?ano, MD, PhD; 57. Down Syndrome; George T. Capone, MD; 58. Coffin-Lowry Syndrome; Michael V. Johnston, MD; 59. Congenital Hypothyroidism; Mary Lee Gregory, MD, PhD; 60. Pediatric Neurotransmitter Disorders; Phillip L. Pearl, MD and William P. Welch, MD; 61. Attention Deficit-Hyperactivity Disorder; Mihee J. Bay, MD and Bruce K. Shapiro, MD; 62. Diseases of Mitochondrial Energy Metabolism; Jacqueline Weissman, MD, MS and Lisa Emrick, MD; 63. Genetic Metabolic Disorders: MethylmalonicAciduria; Siddharth Srivastava, MD and Jeffrey Chinsky, MD PhD; 64. The Urea Cycle Disorders; Andrea L. Gropman, MD, Belen Pappa, MD, and Nicholas Ah Mew, MD; 65. Phenylketonuria; Hilary Vernon, MD, PhD; 66. Cerebral Creatine Deficiency Disorders; Peter W. Schutz, MD and Sylvia Stockler, MD; 67. Congenial Disorders of Glycosylation; Marc C. Patterson, MD, FRACP; 68. Glutaric Aciduria Type I; Hilary Vernon, MD, PhD; 69. Lysosomal Storage Disroders; Gustavo H.B. Maegawa, MD, PhD, FACMG; 70. Peroxisomal Disorders; Gerald V. Raymond, MD, Mohamed Y. Jefri, MD, Kristin W. Baranano, MD, and Ali Fatemi, MD; 71. Leukodystrophies; Ulrike Schrifl, MD, SakkuBai Naidu, MD, and Ali Fatemi, MD; 72. Cerebral Palsy; Joan M. Jasien, MD, Bruce K. Shapiro, MD and Alexander H. Hoon, Jr., MD; 73. Neonatal Brain Injuries; Katharina Goeral, MD, Ali Fatemi, MD, and Michael V. Johnston, MD; 74. The Neurobiology of Encephalopathy of Prematurity; Gwendolyn J. Gerner, MD and Vera Joanna Burton, MD; 75. Epilepsy Syndromes in Childhood; Verena Staedtke, MD and Eric H. Kossoff, MD; 76. Migraine and Headaches in Children; Jessica Klein, MD and Christopher Oakley, MD; 77. Congenital Hydrocephalus; Vera Joanna Burton, MD and Edward Ahn, MD; 78. Spina Bifida and Related Conditions; Stephen L. Kinsman, MD; 79. Smith-Lemli-Opitz Syndrome; Ryan W. Lee, MD; 80. Sickle Cell Anemia; Eboni I. Lance, MD; SECTION VI: Neuroimmunological Diseases (Carlos Pardo-Villamizar, Johns Hopkins University); 81. The Epidemiology of Multiple Sclerosis: An Historical Perspective; Kassandra L. Munger, ScD; 82. Multiple Sclerosis: Pathology; Bogdan Florin Gh. Popescu, MD, Yong Guo, MD, and Claudia Francesca Lucchinetti, MD; 83. Multiple Sclerosis: MRI and Other Imaging Approaches in MS; Martina Absinta, MD and Daniel S. Reich, MD, PhD; 84. Multiple Sclerosis: White Matter vs Grey Matter Involvment (The Cause of Disability in MS); Massimo Filippi, MD, and Maria A. Rocca, MD.; 85. Multiple Sclerosis: Monitoring disease activity and progression; Pavan Bhargava, MD and Shiv Saidha, MBBCh, MD, MRCPI; 86. Symptomatic Treatment of Multiple Sclerosis; Kathleen Costello, RN, BSN, MS; 87. Exercise and Multiple Sclerosis; Jeffrey R Hebert, PT, PhD; 88. Multiple Sclerosis: Disease Modifying Therapies; Pavan Bhargava, MD and Peter A. Calabresi, MD; 89. Neuromyelitis Optica; Teri L. Schreiner, MD, MPH and Jeffrey L. Bennett, MD, PhD; 90. Acute Disseminated Encephalomyelitis; Benjamin M. Greenberg, MD, MHS and Allen Desena, MD; 93. Paraneoplastic Neurological Disorders; John C. Probasco, MD; 94. Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis; Elizabeth M. Wells, MD, MHS; 95. Other Proven and Putative Autoimmune Disorders of the CNS: Anti-GAD Associated Neurological Disorders; Stiff-Person syndrome, Cerebellar Ataxia, Progressive Encephalopathy with Rigidity and Myoclonus (PERM), and Encephalitis.; Scott D. Newsome, DO; 96. Other Proven and Putative Autoimmune Disorders of the CNS: Hashimotos Encephalopathy; Eoin P. Flanagan, MBBCh and Richard J. Caselli, MD; 97. Other Proven and Putative Autoimmune Disorders of the CNS: Neuro-Bechets Syndrome; Afshin Borhani Haghighi M.D and Bernadette Kalman, MD, PhD, DSc; 98. Post-Streptococcal Movement Disorders; Davide Martino, MD and Gavin Giovannoni, MD; 99. Rasmussen Encephalitis; Jan Bauer, MD and Christian G. Bien, MD; 100. Autoimmune Encephalitis; Andrew McKeon, MD; 101. Other Proven and Putative Autoimmune Disorders of the PNS: Myasthenia gravis; Doris G. Leung, MD; 102. Vasculitis of the central nervous system; Christian Pagnoux, MD and Richard H. Swartz, MD; SECTION VII: Cerebrovascular Diseases (Harold Adams, University of Iowa); 103. Stroke Epidemiology and Impact: Mortality, Incidence, Prevalence, Stroke Subtypes, Sex, Race/Ethnicity, Geography U.S. and World; Virginia J Howard, PhD; 104. Acute Ischemic Stroke; Harold P. Adams, Jr., MD; 105. Neuroimaging of Acute Stroke; Chelsea S. Kidwell, MD and Kambiz Nael, MD; 106. Common Risk Factors and Medical Prevention Therapies; George Khouri, MD, Shelly Ozark, MD, and Bruce Ovbiagele, MD, MSc, MAS; 107. Surgical and Radiologic Intervention for Prevention of Ischemic Stroke; Andrew Ringer, MD; 108. Unusual Causes of Stroke; Enrique C. Leira, MD, MS; 109. Pediatric Stroke; Melissa Chung, MD and Warren Lo, MD; 110. Vascular Biology of Cerebral Ischemia; Jason A. Ellis, MD and E. Sander Connolly, Jr., MD; 111. Intracerebral Hemorrhage; Craig Anderson, MD; 112. Subarachnoid Hemorrhage; David Hasan, MD; 113. Genetics of Cerebral Ischemia including Genetic Syndromes; Andrea Porretti, MD and Michael V. Johnston, MD; 114. Molecular Targets of Cerebral Ischemia; Ryan J. Felling, MD, PhD; 115. Sturge-Weber Syndrome and related Cerebrovascular Malformation Syndromes.; Angela Quain, MS and Anne M. Comi, MD; SECTION VIII: Peripheral and Autonomic Nervous System Disorders and Pain (Nicholas Maragakis, Johns Hopkins University); 116. Neuropathies Associated with Infection or Toxic Exposure; Doris Leung, MD; 117. Mechanisms Contributing to the Development and Progression of Diabetic Polyneuropathy; Lucy M. Hinder, PhD, Kelli A. Sullivan, PhD, Stacey A. Sakowski, PhD, and Eva L. Feldman, MD, PhD; 118. Diabetic and PreDiabetic Neuropathy; Lindsay Zilliox, MD and James W. Russell, MD, MS, FRCP; 119. Anatomy, Localization, and Pattern Recognition of Peripheral Neuropathy; Noah Kolb, MD and A. Gordon Smith, MD; 120. Drug Discovery of Neuropathic Pain; Brian J. Wainger, MD, PhD; 121. Neuropathies, Autonomic; Phillip A. Low, MD; 122. Animal Models of Peripheral Neuropathy and Neuropathic Pain; Katelyn Donaldson, MD and Ahmet Höke, MD, PhD; 123. Diagnostic Tests and Clinical Scales for Peripheral Neuropathy; John D. Markman, MD; 124. Complex Regional Pain Syndrome; Frank S. Pidcock, MD; 125. Entrapment Neuropathies; James W. Teener, MD; 126. Demyelinating Neuropathies; John A. Goodfellow, MD, Amy I. Davidson, MD, and Hugh J. Willison, MD; 127. Immune Mediated Neuropathies; John A. Goodfellow, MD, Amy I. Davidson, MD, and Hugh J. Willison, MD; 128. Radiculopathy and Plexopathy; Michael Wheaton, MD, Dustin Nowacek, MD, and Zachary London, MD; SECTION IX: Neoplastic and Paraneoplastic Diseases (Lisa DeAngelis, Memorial Slaon-Kettering Cancer Center); 129. Infiltrative Astrocytomas: WHO grade II - Diffuse Astrocytoma; WHO grade III - Anaplastic Astrocytoma; Aaron Mammoser, MD, MS; 130. Glioblastomas; Aaron Mammoser, MD, MS; 131. Oligodendrogliomas; Thomas J. Kaley, MD; 132. Primary CNS Tumores: Ependymomas; Brett J. Theeler, MD and Mark R. Gilbert, MD; 133. Meningiomas; Jennie Taylor, MD and Patrick Y. Wen, MD; 134. Pineal Region Neoplasms; Neil Haranhalli, MD and Jerome J. Graber, MD, MPH; 135. Pituitary Tumors; Toral R. Patel, MD and Viviane S. Tabar, MD; 136. Primary Central Nervous System Lymphoma; Lisa M. DeAngelis, MD; 137. Familial CNS Tumor Syndromes: Neurofibromatosis Type 1; Ibrahim Hussain, BA and David H. Gutmann, MD, PhD; 138. Familial CNS Tumor Syndromes: Neurofibromatosis Type-2; Jennie W. Taylor, MD and Scott R. Plotkin, MD, PhD; 139. Familial CNS Tumor Syndromes: Tuberous Sclerosis; Darcy A. Krueger, MD, PhD; 140. Familial CNS Tumor Syndromes: Von Hippel-Lindau Disease; Gurvinder Kaur, MD, Leonel Ampie, MD, Joseph Weiner, MD, and Aruna Ganju, MD; 141. Pediatric Tumors: Pontine Glioma; Kristin Schroeder, MD, MPH and Oren Becher, MD; 142. Pediatric Tumors: Medulloblastoma; Kevin C De Braganca, MD and Roger J. Packer, MD; 143. Pediatric Tumors: Cerebellar Astrocytoma; Vijay Ramaswamy, MD, FRCPC, Jason T. Huse, MD, PhD, and Yasmin Khakoo, MD; 144. Brain Metastases; Jasmin Jo, MD and David Schiff, MD; 145. Overview: Other Proven and Putative Autoimmune Disorders of the CNS; Myrna R. Rosenfeld, MD, PhD, Maarten J. Titulaer, MD, PhD, and Josep Dalmau, MD, PhD; 146. Chemotherapy and Radiation Therapy; Mary R. Welch, MD and Craig Nolan, MD; SECTION X: Infectious Diseases of the Nervous System (Karen Roos, Indiana University); 147. Acute Bacterial Meningitis; Pratibha Singhi, MD, PhD, Naveen Sankhyan, MD, PhD, and Sunit Singhi, MD, PhD; 148. Cerebrospinal Fluid; John E. Greenlee, MD; 149. History of Human Immunodeficiency Virus Infection and the Nervous System; Avindra Nath, MD; 150. HIV-Associated Neurocognitive Disorders; Joshua Alexander, DO, MPH, David J Croteau, MD, FRCPC, and Ronald J Ellis, MD, PhD; 151. HIV Infection: Opportunistic Infections in HIV-Infected Individuals; William Tyor, MD; 152. Varicella Zoster Virus Infection of the Nervous System; Don Gilden, MD, Randall J. Cohrs, PhD, Ravi Mahalingam, PhD, and Maria A. Nagel, MD; 153. Brain Abcess; Bela R. Turk, MD, Ali Fatemi, MD, and Michael V. Johnston, MD; 154. Epidural Abscess and Sudural Empyema; Tyler R West, DO and Kelly J Baldwin, MD; 155. Spinal Epidural Abcess; Minal A. Shah, MD and Rabih O. Darouiche, MD; 156. Transverse Myelitis; Ivana Vodopivec, MD, PhD and Tracey A. Cho, MD; 157. CNS Tuberculosis; Andrea T. Cruz, MD, MPH, and Jeffrey R. Starke, MD; 158. Rabies; Alan C. Jackson, MD; 159. Disorders Caused by Botulinum Toxin and Tetanus Toxin; Carl E. Stafstrom, MD, PhD; 160. Rickettsial Diseases; Lisa Sun, MD and Michael V. Johnston, MD; 161. Ehrlichial Diseases; Nicholas S. Havens, MD and William E. Roland, MD, FACP; 162. Nervous System Lyme Disease; John J. Halperin, MD; 163. Congenital and Perinatal Viral Infections; James F. Bale, Jr., MD; 164. Neurologic Manifestations of HTLV-1; Abelardo Q-C Araujo, MD, MSc, PhD, FAAN; 165. Fungal Infections of the Central Nervous System; Pratibha Singhi,MD, Karthi Nallasamy, MD, and Sunit Singhi, MD; 166. Malaria; Kiran Thakur, MD; 167. Babesiosis; Kristyn E. Feldman, MD and Joshua Biddle, MD; 168. Amebic Encephalitis; Pratibha Singhi, MD and Arushi G. Saini, MD; 169. Prions; James A. Mastrianni, MD, PhD and Joshuae G. Gallardo, MD; 170. Neurological Complications of Infective Endocarditis; Jonah Grossman, MD, Tanzila Shams, MD, and Cathy Sila, MD; 171. Post-Infectious Encephalitis; Agusto A. Miravalle, MD; 172. Central Nervous System Whipple Disease; Arun Venkatesan, MD, PhD; 173. Progressive Multifocal Leukoencephalopathy; Arun Swaminathan, MBBS and Joseph R. Berger, MD; SECTION XI: Sleep Disturbances (Mark Dyken, University of Iowa); 174. REM Sleep Behavior Disorder; Shannon S. Sullivan, MD; 175. Restless Leg Syndrome and Periodic Limb Movements in Sleep; Jennifer Accardo, MD, MSCE; 176. Insomnia; Wilfred R. Pigeon, MD and Henry J. Orff, MD; 177. Sleep Apnea; Jennifer Accardo, MD, MSCE; 178. Neurobiology of Circadian Rhythm Disorders; Christopher R. Jones, MD, PhD; SECTION XII: Substance Abuse and Toxicological Disorders (Barry Kosofsky, Weil-Cornell University Medical Centers); 179. Neurologic Manifestations of Organic Chemicals; John L. ODonoghue, VMD, PhD, DABT; 180. Neurobiology of Drug Addiction and Clinical Aspects of Drug Abuse; Leslie R. Whitaker, MD and Bruce T. Hope, MD; 181. Neurological Effects of Marine Toxins; Kazuma Nakagawa, MD; 182. Fetal Alcohol Syndrome; Carmen Lopez-Arvizu, MD, Carmel Bogle, MD, and Harolyn M.E. Belcher, MD, MHS; 183. Fetal Exposure to Tobacco and Cannabis; Edore C. Onigu-Otite, MD; 184. Neurobiology of Child Maltreatment and Psychological Trauma; Nikeea Copeland-Linder, PhD, MPH, Edore Onigu-Otite, MD, Jennifer Serico, PhD, Mariflor Jamora, MD, and Harolyn M.E. Belcher, MD, MHS; 185. Neurobiology of Intrauterine Opiate and Cocaine Exposure; Harolyn M.E. Belcher, MD, MHS and Samantha Hutchison, MD; SECTION XIII: Neurologic Manifestations of Medical Disorders (John Probasco, Johns Hopkins University); 186. Electrolyte Disturbances; Mark N. Rubin, MD and Alejandro A. Rabinstein, MD; 187. Nutritional Deficiencies; Deanna Saylor, MD, MHS and John C. Probasco, MD; 188. Alcohol Abuse; Killian A. Welch, MD; 189. Thyroid Disease; Makoto Ishii, MD, PhD; 190. Parathyroid, Adrenal, Ovarian, Testicular and Pituitary Disease; Gary M. Abrams, MD; 191. Cardiac Disease; Roger E. Kelley, MD; 192. Neurobiology of Brain Injury after Cardiac Arrest; Lucia Rivera-Lara, MD and Romergryko G. Geocadin, MD; 193. Gastrointestinal Disease; Brian P. Bosworth, MD, Brian R. Landzberg, MD, and Elisa McEachern, MD; 194. Neurological Manifestations of Renal Disease; Joshua S. Hundert, MD, Rashmi Verma, MD, Ritika Suri, MD, Anika T. Singh, MD, and Ajay Singh, MD; 195. Systemic Lupus Erythematosis; Richard B. Rosenbaum, MD; 196. Neurologic Manifestations of Hematological Disease; Elham Bayat, MD;
Comments (0)

  • Frequently purchased together

    No products available